• 1. Enantiomerically pure 1,3,2-dioxaborolanes: new reagents for the hydroboration of alkynes
  Chem. Commun., 1998, 2651-2652
• 2. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 5. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrazolopyridines

7-Methyl-Pyrazolo[1,5-a]pyridine (CAS 16205-50-8): A Versatile Heterocyclic Compound with Emerging Applications

In the realm of heterocyclic chemistry, 7-methyl-Pyrazolo[1,5-a]pyridine (CAS 16205-50-8) has garnered significant attention as a structurally unique scaffold with diverse applications. This bicyclic compound, featuring a fused pyrazole and pyridine ring system, serves as a valuable building block in pharmaceutical research, material science, and agrochemical development. The presence of the methyl group at the 7-position imparts distinct electronic and steric properties that influence its reactivity and interaction profiles.

The growing interest in pyrazolo[1,5-a]pyridine derivatives stems from their remarkable biological activities and photophysical properties. Recent studies highlight their potential as kinase inhibitors, with particular relevance to cancer research—a hot topic in current medicinal chemistry. The 7-methyl substituted variant demonstrates enhanced metabolic stability compared to its unsubstituted counterpart, making it particularly valuable for drug discovery programs.

From a synthetic chemistry perspective, CAS 16205-50-8 offers multiple sites for functionalization, allowing medicinal chemists to explore extensive structure-activity relationships. The compound's electron-rich nitrogen-containing system participates in various metal-catalyzed cross-coupling reactions, a subject of intense research in modern synthetic methodologies. These characteristics position 7-methyl-Pyrazolo[1,5-a]pyridine as a privileged structure in fragment-based drug design.

Material scientists have recently explored the optoelectronic applications of pyrazolo[1,5-a]pyridine cores, particularly in organic light-emitting diodes (OLEDs) and photovoltaic devices. The methyl-substituted derivative exhibits favorable charge transport properties and tunable emission characteristics, addressing the growing demand for efficient organic semiconductors in green energy technologies.

The pharmaceutical industry's focus on small molecule therapeutics has driven innovation in heterocyclic chemistry. 7-methyl-Pyrazolo[1,5-a]pyridine serves as a key intermediate in developing potential treatments for neurological disorders—a trending research area responding to global health challenges. Its ability to cross the blood-brain barrier while maintaining structural stability makes it particularly valuable for CNS-targeted drug development.

Analytical characterization of CAS 16205-50-8 reveals interesting spectroscopic features. The methyl group's proton signal typically appears as a sharp singlet in the 2.5-2.8 ppm range in ¹H NMR spectra, while the aromatic protons display characteristic splitting patterns that aid in structural verification—a crucial aspect for quality control in chemical manufacturing.

Recent patent literature indicates growing commercial interest in pyrazolo[1,5-a]pyridine-based compounds, with applications ranging from antimicrobial agents to electronic materials. The 7-methyl derivative's improved solubility profile compared to parent structures enhances its formulation flexibility, addressing a common challenge in drug development pipelines.

Environmental considerations in chemical synthesis have prompted researchers to develop greener routes to 7-methyl-Pyrazolo[1,5-a]pyridine. Modern catalytic methods employing sustainable solvents and reduced metal loadings demonstrate the compound's compatibility with eco-friendly manufacturing principles—an increasingly important factor in chemical industry practices.

The compound's stability under various pH conditions makes CAS 16205-50-8 suitable for diverse formulation approaches. This property, combined with its moderate lipophilicity (predicted logP ~2.1), contributes to its growing popularity in preclinical research, particularly in pharmacokinetic optimization studies.

Emerging computational chemistry approaches have enabled precise prediction of 7-methyl-Pyrazolo[1,5-a]pyridine's molecular interactions. Density functional theory (DFT) calculations reveal interesting electronic distributions across the fused ring system, providing insights for rational drug design—a cutting-edge methodology combining AI and molecular modeling.

Quality standards for pyrazolo[1,5-a]pyridine derivatives continue to evolve, with advanced chromatographic techniques ensuring high purity levels (>98%) for research-grade material. The methyl-substituted variant's crystalline nature facilitates purification processes, an important consideration for scale-up operations in fine chemical production.

Safety evaluations of 7-methyl-Pyrazolo[1,5-a]pyridine indicate favorable toxicological profiles at typical research concentrations. Proper handling procedures—including standard laboratory precautions—ensure safe utilization across various applications, from academic research to industrial development projects.

The global market for specialty heterocyclic compounds like CAS 16205-50-8 shows steady growth, driven by pharmaceutical R&D investments and material science innovations. Custom synthesis services now frequently include this scaffold in their catalogs, responding to increasing demand from drug discovery programs worldwide.

Future research directions for 7-methyl-Pyrazolo[1,5-a]pyridine may explore its potential in combination therapies and multifunctional materials. The compound's structural versatility positions it well for emerging applications in targeted drug delivery systems and smart materials—areas receiving substantial research funding in current scientific initiatives.

• 34760-58-2(Pyrazolo[1,5-a]pyridine, 2-methyl-)
• 319432-37-6(Pyrazolo[1,5-a]pyridine-7-carbonitrile,2-methyl-)
• 885275-64-9({pyrazolo[1,5-a]pyridin-7-yl}methanol)
• 319432-27-4(Pyrazolo[1,5-a]pyridine,7-ethenyl-2-methyl-)
• 319432-35-4(Pyrazolo[1,5-a]pyridine,7-ethynyl-2-methyl-)
• 23935-23-1(Pyrazolo[1,5-a]quinoline, 2-methyl-)
• 60705-36-4(Pyrazolo[1,5-a]pyridine, 2,7-dimethyl-)
• 362661-83-4(Pyrazolo1,5-apyridine-7-carbaldehyde)
• 319432-36-5(Pyrazolo1,5-apyridine-7-carbonitrile)
• 885276-16-4(Pyrazolo1,5-apyridin-7-yl-methylamine)